BioWorld

March 9, 1992

View Archived Issues

APPOINTMENTS AND ADVANCEMENTS

Read More

EXOGENE CLOSES SECOND VENTURE ROUND

Read More

IDEC BEGINS TRIALS OF HIV TREATMENT

Read More

PHASE III DATA BOOSTS IMMUNOMEDICS

Read More

CELTRIX OFFERING BRINGS IN $23.6M

Read More

NEW FUNDS SEE BRIGHT SIDE TO PULLBACK

Read More

IMNR SAYS INVESTORS MISSED THE POINT

Read More